ABOUT LUMAKRAS® (SOTORASIB)

HOW DOES LUMAKRAS® WORK?

Lumakras icon
  • LUMAKRAS® is specifically designed for tumors with the KRAS G12C mutation in non-small cell lung cancer (NSCLC)1
  • In tumors with this KRAS mutation, the protein remains mostly in an “on” position, and cells are continuously forced to grow2
  • LUMAKRAS® targets the mutated KRAS molecule and locks it in the “off” position. This may prevent tumor cell growth3
green-round-icon

If your non-small cell lung cancer is KRAS G12C positive and has been treated with a prior therapy, such as chemotherapy or immunotherapy, ask your doctor if LUMAKRAS® may be able to help.1

NEXT: CLINICAL TRIAL RESULTS